Comparison of latanoprost and timolol in the treatment for exfoliation glaucoma: A randomized controlled trial.

Comparison of latanoprost and timolol in the treatment for exfoliation glaucoma: A randomized controlled trial. - Comparison of latanoprost and timolol for exfoliation glaucoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000425

Enrollment

Registered

2006-06-30

Start date

2006-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exfoliation glaucoma

Interventions

Latanoprost 1 per day for 3 months Timolol 2 per day for 3 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Glaucoma patients with exfoliation material on the lens surface or the pupillary margin. 2. The eyes with the visual acuity of 0.1 or higher. 3. Written informed consent from the patient..

Exclusion criteria

Exclusion criteria: 1. Severe visual field defect. 2. The treatment with latanoprost or timolol within the last 28 days. 3. Allergy to latanoprost or timolol. 4. The past histories of intraocular surgery within the last 3 months or glaucoma surgery. 5. The patients with asthma, heart failure, severe diabetes mellitus or pregnancy. 6. The patients who participated in another drug study within 30 days. 7. Judged inappropriate for this study by the physicians.

Design outcomes

Primary

Measure	Time frame
Intraocular pressure after 3 months	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026